# Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers

> **NCT02758912** · PHASE4 · COMPLETED · sponsor: **Burnasyan Federal Medical Biophysical Center** · enrollment: 32 (actual)

## Conditions studied

- Stroke, Not Specified as Hemorrhage or Infarction
- Angina Pectoris

## Interventions

- **DRUG:** оral intake of study drug capsules; study drug - Cardionat ® (trimethylhydrazinium propionate dihydrate), oral capsules 250 mg

## Key facts

- **NCT ID:** NCT02758912
- **Lead sponsor:** Burnasyan Federal Medical Biophysical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2019-09-25
- **Final completion:** 2019-10-25
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02758912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02758912, "Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02758912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*